Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1950 1
1959 3
1960 1
1961 5
1962 2
1964 2
1965 28
1966 69
1967 68
1968 84
1969 76
1970 75
1971 80
1972 104
1973 76
1974 103
1975 105
1976 88
1977 111
1978 112
1979 147
1980 152
1981 132
1982 135
1983 127
1984 117
1985 133
1986 135
1987 108
1988 124
1989 180
1990 155
1991 127
1992 136
1993 148
1994 182
1995 179
1996 205
1997 190
1998 264
1999 237
2000 237
2001 235
2002 260
2003 264
2004 293
2005 316
2006 343
2007 365
2008 414
2009 460
2010 501
2011 468
2012 531
2013 589
2014 555
2015 618
2016 590
2017 567
2018 611
2019 320
2020 9
Text availability
Article attribute
Article type
Publication date

Search Results

12,319 results
Results by year
Filters applied: . Clear all
Page 1
Diagnosis and Detection of Pancreatic Cancer.
Chu LC, et al. Cancer J 2017 - Review. PMID 29189329
Close attention to secondary signs of pancreatic cancer, such as pancreatic duct dilatation, abrupt pancreatic duct caliber change, and parenchymal atrophy, are critical in the diagnosis of pancreatic cancer. Emerging techniques such as radiomics and molecular imaging have the potential of identifying malignant precursors and lead to earlier disease diagnosis. ...
Close attention to secondary signs of pancreatic cancer, such as pancreatic duct dilatation, abrupt pancreatic duct cal …
Imaging of pancreatic neoplasms.
Balachandran A, et al. Surg Oncol Clin N Am 2014 - Review. PMID 25246049
Ductal adenocarcinoma accounts for 85% to 90% of all solid pancreatic neoplasms, is increasing in incidence, and is the fourth leading cause of cancer-related deaths. ...Pancreatic neuroendocrine neoplasms can have a distinctive appearance and pattern of spread, which should be recognized on imaging for appropriate management of these patients....
Ductal adenocarcinoma accounts for 85% to 90% of all solid pancreatic neoplasms, is increasing in incidence, and is the fourth …
Diagnosis and staging of pancreatic ductal adenocarcinoma.
Guillén-Ponce C, et al. Clin Transl Oncol 2017 - Review. PMID 28612200
The management of pancreatic ductal adenocarcinoma (PDAC) is a major public health concern worldwide. Currently, most PDAC patients are diagnosed in advanced stages. ...In this article, the group of experts proposes strategies to shorten the diagnosis times in PDAC patients....
The management of pancreatic ductal adenocarcinoma (PDAC) is a major public health concern worldwide. Currently, most PDAC patients a …
Pancreatic cystic neoplasms.
Verbesey JE and Munson JL. Surg Clin North Am 2010 - Review. PMID 20362795
Treatment is dependent on accurate diagnosis and tailored to the potential aggressiveness of the lesion, the surgical fitness of the patient, and the probability of effecting long-term palliation or survival of the patient. ...A better understanding of the biologic potential of cystic neoplasms such as intraductal papillary mucinous neoplasms allows for a more patient-specific evidence-based management plan....
Treatment is dependent on accurate diagnosis and tailored to the potential aggressiveness of the lesion, the surgical fitness of the …
A Systematic Review of the Burden of Pancreatic Cancer in Europe: Real-World Impact on Survival, Quality of Life and Costs.
Carrato A, et al. J Gastrointest Cancer 2015 - Review. PMID 25972062 Free PMC article.
The median, age-standardised incidence of pancreatic cancer per 100,000 was 7.6 in men and 4.9 in women. Overall median survival from diagnosis was 4.6 months; median survival was 2.8-5.7 months in patients with metastatic disease. The proportional shortfall analysis showed that pancreatic cancer results in a 98 % loss of healthy life, with a life expectancy at diagnosis of 4.6 months compared to 15.1 years for an age-matched healthy population. ...
The median, age-standardised incidence of pancreatic cancer per 100,000 was 7.6 in men and 4.9 in women. Overall median survival from …
Cystic pancreatic neuroendocrine tumours - a gastroenterologist's point of view.
Dąbkowski K, et al. Endokrynol Pol 2018 - Review. PMID 29952422 Free article.
Guidelines, concerning pancreatic cystic tumors indicate the management with mucinous, serous cystic pancreatic neoplasms and solid pseudopappilary tumor, while the management with pancreatic cystic neuroendocrine tumors is not included into these standards. This review tries to answer the question are the cystic pancreatic neuroendocrine tumors different entity from solid tumors of neuroendocrine origin.The management and differential diagnosis of these neoplasms with special focus on features on imaging studies allowing preoperative diagnosis are discussed....
Guidelines, concerning pancreatic cystic tumors indicate the management with mucinous, serous cystic pancreatic neoplasms
Ultrasound-guided percutaneous fine-needle aspiration of solid pancreatic neoplasms: 10-year experience with more than 2,000 cases and a review of the literature.
D'Onofrio M, et al. Eur Radiol 2016 - Review. PMID 26373764
OBJECTIVES: To evaluate the diagnostic accuracy and complication rate of percutaneous ultrasound-guided fine-needle aspiration (US-FNA) of solid pancreatic neoplasms through the analysis of 10-year experiences of two centres. ...CONCLUSIONS: Percutaneous US-FNA is a sensitive, accurate and safe method for the invasive diagnosis of solid pancreatic neoplasms. ...
OBJECTIVES: To evaluate the diagnostic accuracy and complication rate of percutaneous ultrasound-guided fine-needle aspiration (US-FNA) of s …
Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers.
Vasen H, et al. J Clin Oncol 2016 - Clinical Trial. PMID 27114589
Two individuals (0.9%) in the FPC cohort had a pancreatic tumor, including one advanced PDAC and one early grade 2 neuroendocrine tumor. Thirteen individuals with FPC (6.1%) underwent surgical resection for a suspected PRL, but only four (1.9%) had high-risk lesions (ie, high-grade intraductal papillary mucinous neoplasms or grade 3 pancreatic intraepithelial neoplasms). ...
Two individuals (0.9%) in the FPC cohort had a pancreatic tumor, including one advanced PDAC and one early grade 2 neuroendocrine tum …
Metastatic Pancreatic Cancer.
Hogendorf P, et al. J Invest Surg 2018. PMID 28267398
Comparison of the diagnostic accuracy of the current guidelines for detecting insulinoma
Dauben L, et al. Eur J Endocrinol 2019. PMID 30991361
Objective Insulinomas are rare pancreatic endocrine tumors characterized by hypoglycemia. Guidelines by the Endocrine Society (ES), the European (ENETS) and the North American (NANETS) Neuroendocrine Tumor Societies provide divergent diagnostic criteria. ...
Objective Insulinomas are rare pancreatic endocrine tumors characterized by hypoglycemia. Guidelines by the Endocrine Society (ES), t …
12,319 results
Jump to page
Feedback